Paper4184
Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen.
Blakeley AG and 1 other. Br J Pharmacol, 1976. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen. Papers, record 4184. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4184
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Proceedings: The effects of AH 5158 on the overflow of transmitter and the uptake of (3H)-(--)-noradrenaline in the cat spleen.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ethanolamines | Major topic |
| Labetalol | Major topic |
| Neurotransmitter Agents | Major topic |
| Norepinephrine | Major topic |
| Spleen | Major topic |
| Animals | |
| Cats | |
| Depression, Chemical | |
| In Vitro Techniques |
Source PubMed
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 238,705 | Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. | Br J Pharmacol | 1975 | https://conductscience.org/library/papers/238705 | PubMed |
| 2 | 4,404,413 | Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. | Br J Pharmacol | 1972 | https://conductscience.org/library/papers/4404413 | PubMed |
| 3 | 4,617,579 | Presynaptic regulation of catecholamine release. | Biochem Pharmacol | 1974 | https://conductscience.org/library/papers/4617579 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 2,663,413 | Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease. | Drugs | 1989 | https://conductscience.org/library/papers/2663413 | PubMed |
| 974,401 | The effects of AH 5158 on metabolism of 3H(-)noradrenaline released from the cat spleen by nerve stimulation [proceedings]. | Br J Pharmacol | 1976 | https://conductscience.org/library/papers/974401 | PubMed |
| 191,135 | Pharmacological characterization of presynaptic alpha-adrenoceptors which regulate-cholinergic activity in the guinea-pig ileum [proceedings]. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/191135 | PubMed |
| 25,757 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. | Drugs | 1978 | https://conductscience.org/library/papers/25757 | PubMed |
| 15,698 | The effects of labetalol (AH 5158) on adrenergic transmission in the cat spleen. | Br J Pharmacol | 1977 | https://conductscience.org/library/papers/15698 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4184
GET https://conductscience.org/api/papers/v1/4184/authors